Royal Bank of Canada »

Aikido Pharma shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Aikido Pharma (DOMH) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Aikido Pharma

Tip: Access up to 7 years of quarterly data

All positions including Aikido Pharma held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aikido Pharma by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $17k 2.5k 6.92

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Aikido Pharma

Vanguard Group
Connective Capital Management
Jane Street
Citadel Advisors
BlackRock
Two Sigma Investments
Geode Capital Management
State Street Corporation
Two Sigma Advisers
Millennium Management
Magnus Financial Group
Hrt Financial
Dimensional Fund Advisors
KKM Financial
Northern Trust

View all funds holding Aikido Pharma